Takeda Y - Search Results

1

Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma.

Ohkubo K, Kato Y, Ichikawa T, Kajiya Y, Takeda Y, Higashi S, Hamasaki K, Nakao K, Nakata K, Eguchi K. Ohkubo K, et al. Among authors: takeda y. Cancer. 2002 May 15;94(10):2663-8. doi: 10.1002/cncr.10557. Cancer. 2002. PMID: 12173334 Free article.

2

Full-length sequence and functional analysis of hepatitis B virus genome in a virus carrier: a case report suggesting the impact of pre-S and core promoter mutations on the progression of the disease.

Kajiya Y, Hamasaki K, Nakata K, Nakagawa Y, Miyazoe S, Takeda Y, Ohkubo K, Ichikawa T, Nakao K, Kato Y, Eguchi K. Kajiya Y, et al. Among authors: takeda y. J Viral Hepat. 2002 Mar;9(2):149-56. doi: 10.1046/j.1365-2893.2002.00335.x. J Viral Hepat. 2002. PMID: 11876799

3

A long-term follow-up analysis of serial core promoter and precore sequences in Japanese patients chronically infected by hepatitis B virus.

Kajiya Y, Hamasaki K, Nakata K, Miyazoe S, Takeda Y, Higashi S, Ohkubo K, Ichikawa T, Nakao K, Kato Y, Eguchi K. Kajiya Y, et al. Among authors: takeda y. Dig Dis Sci. 2001 Mar;46(3):509-15. doi: 10.1023/a:1005582812466. Dig Dis Sci. 2001. PMID: 11318524

4

Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression.

Takeda Y, Nakao K, Nakata K, Kawakami A, Ida H, Ichikawa T, Shigeno M, Kajiya Y, Hamasaki K, Kato Y, Eguchi K. Takeda Y, et al. Jpn J Cancer Res. 2001 Sep;92(9):918-25. doi: 10.1111/j.1349-7006.2001.tb01181.x. Jpn J Cancer Res. 2001. PMID: 11572758 Free PMC article.

5

Geranylgeranylacetone induces antiviral gene expression in human hepatoma cells.

Ichikawa T, Nakao K, Nakata K, Hamasaki K, Takeda Y, Kajiya Y, Higashi S, Ohkubo K, Kato Y, Ishii N, Eguchi K. Ichikawa T, et al. Among authors: takeda y. Biochem Biophys Res Commun. 2001 Jan 26;280(3):933-9. doi: 10.1006/bbrc.2000.4228. Biochem Biophys Res Commun. 2001. PMID: 11162614

6

Preparation and in vitro cytotoxicity of a methotrexate-anti-MM46 monoclonal antibody conjugate via an oligopeptide spacer.

Umemoto N, Kato Y, Endo N, Takeda Y, Hara T. Umemoto N, et al. Among authors: takeda y. Int J Cancer. 1989 Apr 15;43(4):677-84. doi: 10.1002/ijc.2910430423. Int J Cancer. 1989. PMID: 2784785

7

Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.

Endo N, Takeda Y, Umemoto N, Kishida K, Watanabe K, Saito M, Kato Y, Hara T. Endo N, et al. Among authors: takeda y. Cancer Res. 1988 Jun 15;48(12):3330-5. Cancer Res. 1988. PMID: 3259466

8

Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.

Kato Y, Saito M, Fukushima H, Takeda Y, Hara T. Kato Y, et al. Among authors: takeda y. Cancer Res. 1984 Jan;44(1):25-30. Cancer Res. 1984. PMID: 6197162

9

In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.

Endo N, Kato Y, Takeda Y, Saito M, Umemoto N, Kishida K, Hara T. Endo N, et al. Among authors: takeda y. Cancer Res. 1987 Feb 15;47(4):1076-80. Cancer Res. 1987. PMID: 3802092

10

An anti-alpha-fetoprotein antibody-daunorubicin conjugate with a novel poly-L-glutamic acid derivative as intermediate drug carrier.

Tsukada Y, Kato Y, Umemoto N, Takeda Y, Hara T, Hirai H. Tsukada Y, et al. Among authors: takeda y. J Natl Cancer Inst. 1984 Sep;73(3):721-9. J Natl Cancer Inst. 1984. PMID: 6206272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,623 results

Search Page

Filters